SCHEMBL6966100

SCHEMBL6966100

C#Cc1cnc2c(c1)C(=O)N(C)c1ccc(F)nc1N2CC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.52
CYP2C9 P11712 4/20 0.52
CYP2C19 P33261 4/20 0.52
CYP1A2 P05177 2/20 0.52
PARK7 Q99497 1/20 0.36
CYP2D6 P10635 1/20 0.35
GABRA5 P31644 7/20 0.34
GABRA1 P14867 6/20 0.34
GABRA2 P47869 6/20 0.34
GABRA3 P34903 6/20 0.34
GABRB2 P47870 5/20 0.34
GABRG2 P18507 5/20 0.32
GABRB3 P28472 5/20 0.32
GABRA6 Q16445 2/20 0.32
GABRA4 P48169 2/20 0.32
CASP3 P42574 1/20 0.32
DCLK1 O15075 1/20 0.31
MAPK7 Q13164 1/20 0.31
LRRK2 Q5S007 1/20 0.31
VRK1 Q99986 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954103 0.87 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL4035380 0.83 CYP3A4 (0.54) CYP3A4CYP2C9CYP2C19CYP1A2PARK7
SCHEMBL6952762 0.82 CYP3A4 (0.51) CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL6959913 0.82 CYP3A4 (0.54) CYP3A4CYP2C9CYP2C19CYP1A2PARK7
SCHEMBL6955968 0.81 CYP3A4 (0.62) CYP3A4CYP2C9CYP2C19CYP1A2PARK7
SCHEMBL5744358 0.80 CYP3A4 (0.65) CYP3A4CYP2C9CYP2C19CYP1A2PARK7
SCHEMBL4680335 0.79 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19CYP1A2PARK7
SCHEMBL6954771 0.78 CYP3A4 (0.66) CYP3A4CYP2C9CYP2C19CYP1A2PARK7
SCHEMBL6955583 0.78 CYP3A4 (0.61) CYP3A4CYP2C9CYP2C19CYP1A2PARK7
SCHEMBL6953433 0.78 CYP3A4 (0.56) CYP3A4CYP2C9CYP2C19CYP1A2PARK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0767172-B1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 2003-03-26 EP disclosed
EP-0767172-A1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1997-04-09 EP disclosed